CCL5



CCL5

S1SS1P2PP2Y3YY3G4GG4S5SS5D6DD6T7TT7T8TT8P9PP9C10CC10C11CC11F12FF12A13AA13Y14YY14L15LL15S16SS16L17LL17A18AA18L19LL19P20PP20R21RR21A22AA22H23HH23V24VV24K25KK25E26EE26Y27YY27F28FF28Y29YY29T30TT30S31SS31S32SS32K33KK33C34CC34S35SS35N36NN36L37LL37A38AA38V39VV39V40VV40F41FF41V42VV42T43TT43R44RR44R45RR45N46NN46R47RR47... and 21 more residue(s)...... and 21 more residue(s)

SMILES None
InChIKey None
Sequence SPYGSDTTPCCFAYLSLALPRAHVKEYFYTSSKCSNLAVVFVTRRNRQVCANPEKKWVQEYINYLEMS

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

CCL5

S1SS1P2PP2Y3YY3G4GG4S5SS5D6DD6T7TT7T8TT8P9PP9C10CC10C11CC11F12FF12A13AA13Y14YY14L15LL15S16SS16L17LL17A18AA18L19LL19P20PP20R21RR21A22AA22H23HH23V24VV24K25KK25E26EE26Y27YY27F28FF28Y29YY29T30TT30S31SS31S32SS32K33KK33C34CC34S35SS35N36NN36L37LL37A38AA38V39VV39V40VV40F41FF41V42VV42T43TT43R44RR44R45RR45N46NN46R47RR47... and 21 more residue(s)...... and 21 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.